Location History:
- Steigstrasses, CH (2003)
- Dachsen, CH (1991 - 2024)
Company Filing History:
11 out of 16 
7 out of 7 
1 out of 1 Years Active: 1991-2025
Title: The Innovations of Martin Ulmann: Pioneering Folate Patents from Dachsen, CH
Introduction: Martin Ulmann, based in Dachsen, Switzerland, is an accomplished inventor with a robust portfolio that includes 19 patents. His contributions primarily focus on the field of folate compounds, which have significant implications in various medical and pharmaceutical applications.
Latest Patents: Among his latest inventions, Martin Ulmann has developed crystalline folate salts. This innovative salt comprises a folate anion, specifically 5-methyl-(6S)-tetrahydrofolic acid, combined with an organic cation that is an alkanolamine. The latter is selected from an array of organic compounds, including choline, N-methylaminoethanol, 2-amino-2-methylpropanol, and 2-dimethylaminoethanol. Additionally, he has created preparations of folate salts designed for topical use, aimed at treating epithelial tissue irritations and skin disorders.
Career Highlights: Throughout his career, Martin has worked with notable companies including Eprova AG and Aprofol AG. His role in these organizations has allowed him to advance his research and patent innovative solutions that contribute to healthcare.
Collaborations: Martin has collaborated with professionals such as Josef Conti and Hans R. Müller. These partnerships have enhanced his work, leading to significant advancements in his field.
Conclusion: As an inventor, Martin Ulmann has made substantial contributions to the understanding and application of folate salts. His innovative patents reflect a commitment to improving health outcomes, showcasing the importance of targeted research and collaboration in the field of medical sciences.